Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

NCRI 2019 | Is age a barrier for chemotherapy?

Nicolò Battisti • 8 Nov 2019

NCRI 2019

General

Nicolò Battisti, MD, The Royal Marsden NHS Foundation Trust, London, UK, talks about age and whether it may be a barrier for patients who may require chemotherapy. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

Extensive DCIS and microcalcifications in patients with breast cancer reaching pCR after NAC

Extensive DCIS and microcalcifications in patients with breast cancer reaching pCR after NAC

Marios Tasoulis et al. • 20 Mar 2021

Escalation of adjuvant therapy in HR+ breast cancer

Escalation of adjuvant therapy in HR+ breast cancer

Nicolò Battisti • 20 Mar 2021

Challenges with chemotherapy in older patients

Challenges with chemotherapy in older patients

Nicolò Battisti • 7 Nov 2019

Related Videos

AI governance and validation in robotic cancer surgery

AI governance and validation in robotic cancer surgery

Marie Hanaoka • 1 Jul 2026

Does toxicity differ between patients treated with SABR for one versus five lesions?

Does toxicity differ between patients treated with SABR for one versus five lesions?

Robert Olson • 16 May 2026

5-year toxicity following SABR: insights from the SABR-5 trial

5-year toxicity following SABR: insights from the SABR-5 trial

Robert Olson • 16 May 2026

How should results from the SABR-5 trial guide future SABR studies?

How should results from the SABR-5 trial guide future SABR studies?

Robert Olson • 16 May 2026